Sustained Virologic Response to Peginterferon α-2a and Ribavirin in 335 Patients with Chronic Hepatitis C: A Tertiary Care Center Experience

BACKGROUND/AIM: This retrospective study assessed the efficacy, safety, and the predictors of sustained viral response (SVR) to a 48-week-course of peginterferon α-2a (Pegasys) and ribavirin combination therapy in 335 consecutive Saudi patients with chronic hepatitis C virus (HCV) infection. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Ashgar, Hamad, Khan, Mohammed Q., Helmy, Ahmed, Al Swat, Khalid, Al Shehri, Abdullah, Al Kalbani, Abdalla, Peedikayel, Musthafa, Al Kahtani, Khalid, Al Quaiz, Mohammed, Rezeig, Mohammed, Kagevi, Ingvar, Al Fadda, Mohammed
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702904/
https://www.ncbi.nlm.nih.gov/pubmed/19568501
http://dx.doi.org/10.4103/1319-3767.39619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702904/
https://www.ncbi.nlm.nih.gov/pubmed/19568501
http://dx.doi.org/10.4103/1319-3767.39619

Ejemplares similares